You should not be hiding the huge debt and dilution of this company. Needless to say, no substantial product even on the market. Too early to pump. Stock is going down the hill. Even if you are a investor truly. I hope you succeed but I suggest you get out and put your money in better pot stocks.
You got to be out of your mind. Check out the debt they are having. No substantial news by any means. Are you a pumper.
Sentiment: Strong Buy
If you really like #$%$ stocks, there are few good one out there GW, INSY.
Sentiment: Strong Buy
An excellent resource for any trader, these guys are constantly finding the right play at the right time for their members and providing quality reports that are backed by solid technical and fundamental analysis that highlights the real potential of the featured company.
What kind of week will SRNA put together, well ExplosiveOTC is following their developments and those of a handful of potential blockbusters, find out who the next breakout star will be and when you sign up you'll receive an incredible ebook- just enter the code SRNA.
This management knows how to build a big business and I'm very impressed how they go about it.
If you're investor or just started doing your DD, FYI: the transcript of the CC will be available later this week - a must read.
I told you weeks ago....IBIO is just starting!!!
Sentiment: Strong Buy
During the year, the Company raised $ 2,961,000 through the issuance of convertible debt and $ 911,000 in additional subsequent offer to year end.
The Company Entered in 2015 with $ 408.200 in contracts in progress thatwere During 2014; CORRESPONDING revenue which deferred pending completion of the 2015 into contracts.
Barica Investements notes that from circa May 2014, the business was first recorded. That 2015: double revenue and 500,000 dollars from the 2014th
Without increased sales, annual sales of 6.5 million for the 2015th
We assume that at least 13 million are generated.
Market capitalization as of today: 13 million.
Thus, the company is valued by today to A in annual sales.
Patents are not logged in. This was postponed, as this also with
is connected substantial costs.
We see 2016 annual revenues of at least 100 million.
That is what every child understands, fair value is 8 times the current rate, ie 88 US cents.
In two years, we see a price target of $ 3 as a conservative target price.
Tomorrow we report in detail.
The stock is personally recommended for 10,000 customers.
As of Tuesday, Wednesday.
Whats App Group:
0049 151 588 47 050 - It's Free!
Good luck, regardless of whether or where you are investing.
CEO Barica Investments
Surna - Strong Buy in Germany - Austria - Switzerland - Italy
STRONG BUY - PRICE TARGET 1 Dollar
from Barica Investments Germany
Surna Inc. (SRNA) - Strong Buy - Price Target 1,00 US-Dollar.
here the statement from Barica Investement
BAvaria RIsk CApital
Munich - Salzburg - Zurich - Rome
WhatsApp-Group: 0049-151-588 47 050
A Start Up - Company whith finance Start Ups - a
Venture Capital company - Bavarian Risk Capital -
Barica Investments - Munich.
Here is the recommendation of Barica investments.
go to the german website "finanzen dot net"
write "surna inc"
then "im forum"
its the german message board
The recommendation is greatly expanded.
These are the remarks on the board.
It would be nice of you if you register with finanzen.net. Free. Write down your impressions English, as here. It would be very happy.
Next week throughout Germany, Austria, Switzerland and Italy.
Bernd from Munich - Kingdom of Bavaria !
Surna Inc SRNA is more than undervalued.
For the year ended December 31, 2014 the Company had gross Revenues of $ 1,838,912 and on a pro forma combined basis with Hydro Innovations it had great Revenues of $ 2,488,837. The net loss for the year and combined pro forma loss $ 2,991,969 and $ 3,263,320 werewolf, respectively.
Surna established its foundation as a technology-based company, spending $ 319.430 on research development for new technology and products, accounting for 17% of the Company's revenue. The Company spent $ 240.784 for advertising and marketing to advance its products and brand recognition. Its general and administrative expenses $ 2,636,244 werewolf, w
Which included a non-recurring one-time non-cash expense of $ 1,330,000.
The Company finished the year with a balance sheet did included liquid assets (cash, accounts receivable, inventory and prepaid assets) of over $ 1,400,000 while current accounts payable in cash Totaled $ 725.231, 303.672 USD End of month is payable to Shareholders.
Consider 1.5 million per quarter x 4, that's $6M yearly Revenue.
Most companies trade at a Market Cap of this value, unless they are very profitable.
SRNA is currently at a market cap of $12M, or $0.11 per share.
You basically just said you think SRNA should be worth $6M or $0.055 per share, and then said you think it should be $1.00 soon.
To correct yourself, you think it's going to fall to around $0.06.
That's actually more bearish than me. I think it's going down to $0.08 during this quarter.
They have about 500k left over from 2014 and signed the large 1.2 Million in the 1st quarter of 2015. They're headed in the right direction and with the new products should explode by the end of this year! I see a dollar eventually if they can keep this thing going.
To value the company at $0.13 per share, I valued SRNA at $13.25M back on Nov 11, 2014.
Since then, SRNA has lost $3.3M and gained nothing of value.
Therefore, fair value is $0.10 per share, or $10M market cap for today. Considering it's trading at $0.11 is 10% higher than it deserves.
I conclude it keeps falling.
My target is $0.08, which assumes they will lose another $3M going forward for the next quarter or two.
I'll check back in another 3 months to lower it beyond $0.08 when it arrives.
I perform these checks because I like bargains, but SRNA isn't there yet.
Perhaps when SRNA is down around $0.08 with losses not nearly as large as the recent $3.3M, then I will consider going long.
The losses have to stop or you are looking at $0.001 as the future
Sentiment: Strong Sell
I am going to back norstodamus and say goal is .30-.50 for a year. I expect they will have good progress by end of year, but nothing substantial for growth that big.
I called this drop to $0.13 right from the beginning of this Board, back then it was $0.41.
Now that my target has been reached I'm going to reevaluate SRNA to see my new estimate.
I think it's worth less than 10cent right now, but I'll prove it shortly by the fundamentals.
I still believe it's not a buy even though it crossed below my $0.13 target.